You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Exploring a new direction in targeted cancer therapy through hyperbaric oxygen therapy combined with biomedical engineering techniques
- 2. The role and mechanisms of exosome microRNA in regulating metastasis within the tumor microenvironment of prostate cancer
- 3. Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties
- 4. What surviving cancer outliers can teach us: The tech behind a new paradigm in oncology
- 5. Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence
- 6. Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms
- 7. [Latest] Global Neoantigen Cancer Vaccine Market Size/Share Worth USD 1.98 Billion by 2034 at a 15.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- 8. Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
- 9. Pancreatic cancer vaccines eliminate disease in preclinical trials
- 10. Your favorite alcoholic beverage could be linked to deadly form of cancer, study finds
Last updated at 7:21 GMT
Hot News Makers
Health/Pharma Companies
-
34613.00
-
20682.49
-
13096.94
-
12945.62
-
8572.63
-
4338.02
-
3405.20
-
3136.79
-
1648.88
-
1591.74
Drugs, Treatments, Trials
-
29957.95
-
28088.14
-
16774.61
-
10895.39
-
7725.62
-
6401.15
-
3180.01
-
3099.35
-
2983.89
-
2310.81
Last updated at 7:10 GMT
